These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 15087667

  • 41. Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations.
    Terada T.
    Med Oncol; 2009; 26(2):233-7. PubMed ID: 18777214
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.
    Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD.
    Am J Surg Pathol; 2004 Jul; 28(7):889-94. PubMed ID: 15223958
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S, Chen LR, Wang HJ, Chen SZ.
    Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, Reid-Lombardo KM, Kendrick ML, Bingener-Casey J, Tang CM, Sicklick JK, Gibbons SJ, Farrugia G, Taguchi T, Gupta A, Rubin BP, Fletcher JA, Ramachandran A, Ordog T.
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Mutations of the c-Kit and PDGFRA gene in gastrointestinal stromal tumors among hakka population of Southern China.
    Wang S, Zhang Q, Wu H, Yang Z, Guo X, Wang F, Yu Z, Zhong Z.
    Niger J Clin Pract; 2021 Jun; 24(6):814-820. PubMed ID: 34121727
    [Abstract] [Full Text] [Related]

  • 52. Results on prognostic value of mutations in localized gastrointestinal stromal tumors (GIST) in one single center.
    Garcés-Albir M, Marti-Obiol R, López-Mozos F, Calabuig-Fariñas S, Navarro-Ros S, Ortega-Serrano J.
    Rev Esp Enferm Dig; 2012 Aug; 104(8):405-10. PubMed ID: 23039800
    [Abstract] [Full Text] [Related]

  • 53. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
    Sápi Z, Füle T, Hajdu M, Matolcsy A, Moskovszky L, Márk A, Sebestyén A, Bodoky G.
    Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036
    [Abstract] [Full Text] [Related]

  • 54. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
    West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M.
    Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
    [Abstract] [Full Text] [Related]

  • 55. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Gao J, Li J, Li Y, Li Z, Gong J, Wu J, Liu N, Dong B, Qi C, Li J, Shen L.
    Oncotarget; 2016 May 24; 7(21):30241-9. PubMed ID: 26848617
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
    Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y.
    Cancer Res; 1999 Sep 01; 59(17):4297-300. PubMed ID: 10485475
    [Abstract] [Full Text] [Related]

  • 58. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M, Majidi M, Lasota J.
    Eur J Cancer; 2002 Sep 01; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [Abstract] [Full Text] [Related]

  • 59. Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.
    Sihto H, Franssila K, Tanner M, Vasama-Nolvi C, Sarlomo-Rikala M, Nupponen NN, Joensuu H, Isola J.
    Scand J Gastroenterol; 2006 Jul 01; 41(7):805-11. PubMed ID: 16785193
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.